Paxlovid 150 mg + 100 mg film-coated tablets clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
TURN-COVID Biobank: The Dutch cohort study tor the evaluation of the use of neutralizing monoclonal antibodies and other antiviral agents against SARS-CoV-2
This study looks at how well certain COVID-19 treatments work, such as Ronapreve, Evusheld, Xevudy, and Paxlovid. It’s also building a collection of samples to help understand these treatments and new ones in the future. The study is for adults with COVID-19.
For: SARS-CoV-2 infectionNetherlands - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19
This study is testing new treatments for COVID-19 in people who are at higher risk of becoming very unwell. It compares a new medicine called Bemnifosbuvir with usual care and Paxlovid to see if it helps prevent serious illness or hospital stays.
For: COVID-19Latvia · Netherlands · Sweden - AuthorisedTherapeutic exploratory (Phase II)
Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone for Coronavirus Disease 2019 (COVID-19) in Patients with Severely Impaired B-cell Function
This study is testing a medicine called Privigen for people with COVID-19 who have a weakened immune system. It aims to see if adding Privigen to standard care helps them recover better than standard care alone.
For: COVID-19 and Severely Impaired B-cell FunctionSweden